Solid Biosciences (SLDB) Change in Accured Expenses (2017 - 2024)
Historic Change in Accured Expenses for Solid Biosciences (SLDB) over the last 8 years, with Q4 2024 value amounting to $1.6 million.
- Solid Biosciences' Change in Accured Expenses rose 19872.34% to $1.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.8 million, marking a year-over-year increase of 16840.82%. This contributed to the annual value of $4.8 million for FY2024, which is 16840.82% up from last year.
- Latest data reveals that Solid Biosciences reported Change in Accured Expenses of $1.6 million as of Q4 2024, which was up 19872.34% from $3.3 million recorded in Q3 2024.
- In the past 5 years, Solid Biosciences' Change in Accured Expenses ranged from a high of $8.7 million in Q2 2022 and a low of -$5.0 million during Q3 2022
- For the 5-year period, Solid Biosciences' Change in Accured Expenses averaged around $10950.0, with its median value being -$341000.0 (2021).
- Within the past 5 years, the most significant YoY rise in Solid Biosciences' Change in Accured Expenses was 151500.82% (2022), while the steepest drop was 154437.09% (2022).
- Over the past 5 years, Solid Biosciences' Change in Accured Expenses (Quarter) stood at $887000.0 in 2020, then surged by 190.42% to $2.6 million in 2021, then dropped by 0.27% to $2.6 million in 2022, then tumbled by 164.03% to -$1.6 million in 2023, then surged by 198.72% to $1.6 million in 2024.
- Its Change in Accured Expenses stands at $1.6 million for Q4 2024, versus $3.3 million for Q3 2024 and -$380000.0 for Q2 2024.